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In recent years, there has been a substantial increase of imported Plasmodium vivax incidence in Henan Province.
As China is in a pre-elimination phase, the surveillance of imported malaria is essential, but there is no good way to
distinguish imported cases from indigenous cases. This paper reports a case of a 39-year-old man who acquired
P. vivax while staying in Indonesia for one month in 2013, and relapsed in Henan, China in 2014. This was diagnosed as
vivax malaria based on rapid diagnostic test, Giemsa-stained peripheral blood smear and Plasmodium species-specific
nested PCR. The genetic sequence for the circumsporozoite protein genes was analysed and the genetic variations
were compared with a previously constructed database of Chinese isolates. The results from the circumsporozoite
protein (CSP) gene sequence analysis centered on the repeat patterns showed that the imported cases had completely
different sequences from any subtypes from Chinese isolates, but well matched with the countries travelled by
the patient. The imported vivax cases were able to clearly distinguish from the indigenous vivax cases by detecting the
CSP gene and were able to confim its origin by genotyping.
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Malaria is a parasitic infection caused by Plasmodium
falciparum, Plasmodium vivax, Plasmodium malariae
and Plasmodium ovale. Globally, between 135 and 287
million people were infected in 2012, of which over
600,000 died [1]. In China, malaria seems to have been
known for over 4,000 years and was identified as one of
the top five parasitic diseases that affected seriously the
socio-economic development after the establishment of
the People’s Republic of China in 1949 [2]. In the early
1950s, a malaria epidemic spread in 1,829 counties, i.e.,
70-80% of all counties in China [3].
In Henan Province, malaria has been a major health
problem historically. Plasmodium vivax was endemic in
the whole province, while P. falciparum was prevalent in
the regions south of 33° latitude north. In the early
1970s, the morbidity reported was 16.9%, the number of
the malaria cases was highest in the country [4]. After-
wards, the reported malaria cases have declined* Correspondence: bianlixu@163.com
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unless otherwise stated.dramatically through years of efforts, and no local case
was reported by the end of 2012, and all the cases were
identified as imported. In order to better protect and
promote public health, the Henan government carried
out an action plan of malaria elimination as a guidance
document in 2010, with a goal to eliminate local malaria
transmission by 2015 and malaria completely by 2018 [5].
Therefore, the data from each of the cases were analysed
carefully to distinguish whether the case was autochthon-
ous or imported since 2013.
This study aimed at a case of imported P. vivax from
Southeast Asia, who relapsed three months after leaving
there, this case was diagnosed by light microscopy, rapid
diagnostic test(RDT), nested PCR and sequence analysis.
It was the first imported relapse case recorded in Henan
Province.Case presentation
Clinical history and laboratory findings
During the work of anti-relapse treatment in 2014, a
malaria patient was met by chance, who had a malaria his-
tory last year. The patient was a 39-year-old Chinese manThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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headache; he reported no other constitutional symptoms
and without underlying diseases.
At the time of his illness, the patient had lived for about
four months in Lankao, which has not been a malaria en-
demic area in Henan Province. However, before getting
back to Lankao, he had been a trucker for one month in
Indonesia, a malaria-endemic country. During his stay in
Indonesia, he did not have any symptoms related to
malaria and did not receive any treatment for malaria.
But when he had just come back on 2nd December 2013,
he suffered a sudden onset of rigors. He was diagnosed with
malaria on 6th December 2013. This case was microscopic-
ally identified to be P. vivax (Figure 1), the number of mal-
arial parasites per 200 WBCs with a microscope at × 1,000
was counted, assuming 8,000 WBCs per microlitre, and the
densities of malarial parasites for the patient were 330/μl.
He was treated with a full course of dihydroartemisinin and
piperaquine phosphate tablets and primaquine. He did not
travel to any other malaria endemic areas after that.
The patient was thoroughly examined. The RDT (Wondfo
Biotech Co., Ltd, China) for malarial antigen was positive.
The peripheral blood sample showed P. vivax malaria
by microscopic examination of Giemsa-stained thick and
thin blood films; this diagnosis was confirmed at Henan
CDC by microscopy experts (Figure 1). The densities of
malarial parasites for the patient were 5,760/μl.
The patient was treated with dihydroartemisinin and
piperaquine phosphate tablets (immediate dose of 800 mg,
followed by 400 mg at 6, 12, 18, and 24 hr) and primaquine
(22.5 mg/day for 8 days). He had a rapid and favourable
response, his symptoms began to subside after one day
of treatment, on the 10th day, the parasites were not
observed.
Plasmodium species-specific nested PCR
For the 18S rRNA, nested PCR was performed. DNA
was extracted from the patient’s blood samples with theFigure 1 Subject’s malaria smear. Giemsa-stained peripheral blood smea
and in the relapse (d, e, f).QIAamp DNA Mini kit (QIAGEN Inc, German) according
to the manufacturer’s instructions and stored at −20°C.
Plasmodium genus-specific set (rPLU1/rPLU5) was used
for the first-round PCR. Other four pairs of species-specific
primers (rFAL1/rFAL3 for P. falciparum, rVIV1/ rVIV2 for
P. vivax, rMAL1/rMAL2 for P. malariae, and rOVA3/
rOVA4 for P. ovale) that had been reported in a previous
study were used in the second-round PCR [6]. Nested PCR
was performed using a DNA thermal cycler (iCycler iq-5,
Bio-Rad Laboratories, Hercules, California, USA). Primers
were provided by Sangon Biotech Co. Ltd, China. Thermal
cycling was carried out under the following conditions: ini-
tial denaturation at 94°C for 5 min, annealing at 58°C for
30 sec, and extension at 72°C for 60s (34 cycles), and final
extension at 72°C for 5 min (30 cycles). The four previ-
ously diagnosed clinical samples (P. falciparum, P. vivax, P.
malariae, P. ovale) and pure water was used as the positive
and negative controls, respectively. The amplified DNA
product corresponded to P. vivax (120 bp). The presence
of P. vivax in the patient’s specimen was confirmed by
nested PCR.Genotyping analysis
The polymorphic regions of the circumsporozoite protein
(CSP) genes from the DNA samples were amplified and
sequenced. The primers and amplification conditions were
described by Imwong M et al. [7]. The CSP genes from
the case and other relative sequences were analysed: three
sequences from the National Centre for Biotechnology In-
formation, 27 sequences from previous studies [8], one se-
quence from the patient’s previous infection (Case 2013),
another sequence from his follow-up (txry 2013). It has
been found that the sequence from the case (case 2014)
nearly had the same CSP sequence as ‘Case2013’ and
‘txry2013’, its sequence was also similar to the Indonesian
isolate (AFI80542) with small modification of the repeat
number (the case was 18, the Indonesian isolate was 17),r at the time of presentation (×1,000) in the primary infection (a, b, c)
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(Figure 2).
Multiple sequence alignment of all the genes sequences
and loci was performed with the algorithm Clustal X soft-
ware. Phylogenetic trees were constructed using the
Molecular Evolutionary Genetics Analysis(MEGA) 4.0 and
their reliability was tested by bootstrapping analysis (1,000
replicates). One cluster was considered significant if it was
present in more than 75% of the permuted trees (Figure 3).Figure 2 Amino acid sequence comparison of CSP from P. vivax. Amin
determined in the present study and from Indonesia were analyzed. The G
(AFI80542 the sequence was collected in 2003 in Borneo Indonesia), U0897
(M28746). HNZK1, HNZMD1, HNNY1-8, HNSQ1-14, 18, 21, 26 were collected
present study.Discussion
The case with a history of P. vivax infection, had fever,
chills, headache for one day, but no other constitutional
symptoms. Meanwhile, patient’s current residence, Lankao
is a non-endemic area for malaria. Only considering his
travel history and historical exposure to P. vivax, given the
related examination of malaria, the result was positive.
This case suggested it was necessary to obtain the epi-
demiological history when formulating a diagnosis ando acid sequences previously found in Chinese P. vivax isolates,
enbank database accession numbers are as follows: Indonesia
7(the sequence was collected in 1994 in Guizhou, China), VK210
in 2011 in Henan,China. Case 2013 and txry2013 were from the
Figure 3 Neighbour-joining tree of CSP from P. vivax. Subtree
including the patient’s strain and depicting its phylogenetic
relationship with other strains (VK210: M28746, VK247: M28745).
Bullets represent >75% bootstrap value (1,000 replicates).
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etiologies for febrile illnesses, which was especially im-
portant in the current era of globalization and increas-
ing residential mobility [9].
This was the first report of a relapse P. vivax case from
an endemic area in Henan Province. Malaria relapse refers
to the re-emergence of the malarial paroxysm after several
weeks to more than one year without malarial parasites
infection when the parasitemia in the erythrocytic stage
has been eliminated at the first onset of malarial patients,
which is possiblly related to activated hypnozoites. Relapsa-
ble malaria includes vivax and ovale malaria and other
monkey malaria. This case reminded everyone, when facing
a patient with fever of unknown origin, obtaining a thor-
ough long-term residential and the history of the spread of
malaria is very essential.The patient’s primary attack of malaria began on 2nd
December 2013, he was diagnosed with vivax malaria
on the fifth day, the densities of malarial parasites were
330/μl at that time. Then he suffered a relapse on 23th
March, was diagnosed on the second day, but the dens-
ities of malarial parasites were 5760/μl. The case also
showed us, the patients maybe had more tolerance to the
malarial parasites when they were suffering a relapse. So
in the relapse patients, the disease would develop more
rapidly than those with primary infection.
CSP is found in all the mature malaria parasites, which
forms a dense coat on the sporozoite’s surface [10]. It
comprises three distinct domains: a central repetitive
domain with a variable number of tandem repeats, and
2 highly conserved non-repetitive terminals. The central
repetitive domain from the CSP varies in sequence and
length among Plasmodium spp [11]. The P. vivax VK210
strain has CSP amino sequence that includes a GDRAA/
DGQPA repeat [12,13]. A variant form, VK247, later iden-
tified in Thailand in 1989, possesses an ANGAGNQPG
amino acid repeat in the central region [14]. This poly-
morphic marker was useful for genetic epidemiological
surveys where P. vivax is endemic.
According to the previous studies, the amino acid se-
quence of this case in the CSP regions belonged to the
VK210 type [15,16]. For further analysis, the sequence
from the case was identical to the sequence he had be-
fore (Case 2013) and the sequence from his follow–up
(txry2013). At the same time, it showed similarity to the
isolate from Indonesia (AFI80542) where the patient had
recently travelled, but was different from any of the
Chinese isolates. Phylogenetic analysis in the CSP region
showed that the investigated strain was related with the
strains from Indonesia.
Conclusions
In this particular case, the patient had been in Indonesia
for one month about half year before and the clinical
symptoms were not specific, however, malarial parasites
were observed in the peripheral blood smear, the nested
PCR also supported the result. Considering the test re-
sults and his travel history, it could be guessed that he
was infected with P. vivax during his stay in Indonesia
rather than in China. Therefore, careful history taking,
including the current residency and travel history, is im-
portant to make the diagnosis of malaria. Genotyping is
a useful tool to determine the origin of vivax malaria and
discriminate imported cases from autochthonous cases. It
is very significant in the elimination era.
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